Yuan detected that the miR-616 increased proliferation and migration of BC cells by directly affecting the TIMP2 and emphasizing the role of miR-616/TIMP2/MMP axis as a novel therapeutic target [69]. This evidence concerns the gene TIMP2 and breast cancer.